Pharmaceutical
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Cosmetic Raw Material
OEM & ODM
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales28@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
palmitamide mea raw material Powder
Product Overview:
Cetamide ethanol (PEA) is an endogenous fatty acid amide and belongs to the class of nuclear factor agonists. It has been shown to bind to nuclear receptors (nuclear receptors) and exert a great variety of biological functions related to chronic pain and inflammation.
palmitamide mea raw material Powder Attributes
CAS:544-31-0
MF:C18H37NO2
MW:299.49
EINECS:208-867-9
Specification: 99% min palmitamide mea Powder
Sample:palmitamide mea Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance:white
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
palmitamide mea raw material Powder Details
palmitamide mea powder Usage and Synthesis.
Cetamide ethanol is an organic synthesis intermediate and pharmaceutical intermediate, which can be used in laboratory research and development process and chemical pharmaceutical research and development process. PEA has been shown to have anti-inflammatory, anti-sensory injury, neuroprotective, and anticonvulsant properties. PEA has been exploring various pain states in people in different clinical trials on inflammation and pain syndromes.
Uses of palmitamide mea.
In vitro study of palmitamide mea.
PEA can effectively prevent glutamate toxicity of rat cerebellar granule cells and enhance the motility of microglia. In mitochondrial fragments of cells stimulated with PEA, expressions of steroid synthesis Rapid regulatory protein (StAR) and P450scc were increased, including some of the proteins responsible for the formation of neurosteroids. PEA also has a protective effect, such as reducing malondialdehyde formation in cells treated with L-buthionine-(S,R)-sulfoximine, which causes glutathione deficiency. The effect of PEA is partially inhibited by finasteride (5A-reductase inhibitor).
Product Methods of palmitamide mea.